Status:
RECRUITING
Hormone Replacement Trial Against ALzheimers' Disease
Lead Sponsor:
University Hospital, Ghent
Conditions:
Postmenopausal Symptoms
Alzheimer Disease
Eligibility:
FEMALE
40-65 years
Phase:
NA
Brief Summary
The influence of postmenopausal hormone treatment on dementia is not clear. Dysfunctions in the metabolism of amyloid in the disease of Alzheimer result in an elevated presence of degradation products...
Eligibility Criteria
Inclusion
- postmenopausal women
- 40 - 65 years
Exclusion
- Longer than 10 years in menopause
- thyroid dysfunction
- hypertension
- medical history of psychiatric comorbidity
- Alcohol and/or drug abuse
- medical history of neurologic symptoms with cognitive symptoms
Key Trial Info
Start Date :
April 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04312399
Start Date
April 17 2018
End Date
December 31 2028
Last Update
January 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent university hospital
Ghent, Belgium, 9000